Key points are not available for this paper at this time.
-synephrine may be a potential alternative strategy for developing novel anti-obesity drugs.
Lee et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: